1.14
8.06%
-0.10
Zyversa Therapeutics Inc (ZVSA) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
81.80%
-0.000101
|
-0.000555 | -0.00021 | -0.000314 | 0.00108 |
Operating Expenses
|
79.71%
2.8266
|
13.93 | 2.9027 | 86.33 | 4.5921 |
Benefits Costs and Expenses |
2.8266
|
- | 2.9027 | 86.33 | - |
Costs And Expenses |
2.8266
|
- | 2.9027 | 86.33 | 4.5932 |
Provision For Loan, Lease, And Other Losses |
-
|
- | - | - | - |
Operating Income/Loss |
79.71%
-2.8266
|
-13.93 | -2.9027 | -86.33 | -4.5921 |
Net Interest Income/Expense |
-0.000101
|
- | -0.00021 | -0.000314 | 0.00108 |
Interest Income/Expense After Provision For Losses |
-0.000101
|
- | -0.00021 | -0.000314 | 0.00108 |
Income/Loss From Continuing Operations Before Tax |
79.71%
-2.8267
|
-13.93 | -2.9029 | -86.33 | -3.544 |
Income/Loss From Continuing Operations After Tax |
87.60%
-2.8267
|
-22.79 | -2.9024 | -78.51 | -3.544 |
Net Income/Loss
|
78.81%
-2.8267
|
-13.34 | -2.9024 | -78.51 | -3.544 |
Preferred Stock Dividends And Other Adjustments |
100.00%
-
|
-7.9158 | 0.0843 | 7.9158 | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
103.38%
0.6236
|
-18.43 | 30.98 | 17.86 | 9.1285 |
Diluted Average Shares |
103.38%
0.6236
|
-18.43 | 30.98 | 17.86 | -4.3384 |
Basic Earnings Per Share |
95.65%
-4.53
|
-104.18 | -0.09 | -4.84 | -0.39 |
Diluted Earnings Per Share |
95.65%
-4.53
|
-104.18 | -0.09 | -4.84 | -1.82 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
100.00%
-
|
-7.9158 | 0.0843 | - | - |
자본화:
|
볼륨(24시간):